582 Companies
Clinical-stage biopharmaceutical company, Abeona Therapeutics Inc., is at the forefront of developing gene and cell therapies to address life-threatening diseases. The company's flagship clinical p...
Abeona Therapeutics Annual Report 2023Singapore-based Wave Life Sciences Ltd., a clinical-stage genetic medicine company, has developed a discovery and drug development platform called PRISM which enables it to design, optimize, and pr...
WAVE Life Sciences Ltd. Annual Report 2023Galapagos NV, a European biopharmaceutical company, has made significant strides in the development of medicines for high unmet medical needs. With a robust pipeline of products, the company aims t...
Galapagos Annual Report 2023Miami-based OPKO Health, Inc. has established itself as a key player in the healthcare industry. The company operates in the diagnostics and pharmaceutical sectors in the United States, Ireland, Ch...
OPKO Health Annual Report 2023Late-stage clinical firm, Prothena Corporation plc, is aiming to combat diseases that result from protein dysregulation in the United States, with a focus on novel therapy development. Currently, t...
Prothena Corp Annual Report 2023Headquartered in Palo Alto, California, Eiger BioPharmaceuticals has established itself as a prominent commercial-stage biopharmaceutical company that specializes in developing and commercializing ...
Eiger BioPharmaceuticals Annual Report 2023IMV Inc: Clinical-Stage Immuno-Oncology Company Develops Therapies Based on DPX Technology for Cancer Treatment IMV Inc., a Canadian-based clinical-stage immuno-oncology company, has developed a p...
Imv Annual Report 2021Charlottesville-based biopharmaceutical company Adial Pharmaceuticals, Inc. is making strides in the clinical-stage development of therapeutics for addiction and related disorders. The company's fl...
Adial Pharmaceuticals, Inc Annual Report 2023SIGA Technologies, a New York-based commercial-stage pharmaceutical company, is targeting the health security markets in the United States. The company's primary focus is on TPOXX, an oral antivira...
SIGA Annual Report 2023InflaRx N.V., a clinical-stage biopharmaceutical company specializing in C5a technology, is making waves in Germany and the United States with its unique inhibitors. C5a, an inflammatory mediator i...
InflaRx N.V. Annual Report 2023TG Therapeutics, Inc., a commercial biopharmaceutical company, is dedicated to acquiring, developing, and commercializing innovative treatments for B-cell diseases, such as BRIUMVI, an anti-CD20 mo...
TG Therapeutics Annual Report 2023San Diego-based biotherapeutics company aTyr Pharma is focused on discovering and developing novel immunological pathways for the creation of new medicines. Its lead candidate, efzofitimod, is curr...
Lifecare Annual Report 2023PYC Therapeutics Limited is a biotechnology company based in Australia that focuses on the discovery and development of drug solutions in ribonucleic acid therapeutics. The company's preclinical de...
PYC Therapeutics Limited Annual Report 2023Apellis Pharmaceuticals Inc., a biopharmaceutical company, recently announced it is making strides in the discovery, development, and commercialization of therapeutic compounds for autoimmune and i...
Apellis Pharmaceuticals Annual Report 2023Baudax Bio, Inc., a pharmaceutical company specializing in hospital and acute-care products, has recently introduced their latest product, ANJESO (meloxicam), for the management of moderate to seve...
Baudax Bio, Inc. Annual Report 2021